0
Skip to Content
Phelan-McDermid Syndrome
For Academia & Industry
Learn about our Initiatives
Our Research Grants
PMS Conceptual Model
EL-PFDD Meeting
CureSHANK Consortium
Funding Opportunities
Research Resources
Landscape Analysis for Industry
Participate in Research
Support Our Work
Our Fundraisers
Take Action
Fundraise Online
Plan an Event
Media
Real Family Stories
Webinars
PMSAD
News
CureSHANK Pressroom
About Us
Board of Directors
Strategic & Scientific Advisors
Our Partners
Financials
Meet Our Team
Contact Us
Donate
Open Menu
Close Menu
Phelan-McDermid Syndrome
For Academia & Industry
Learn about our Initiatives
Our Research Grants
PMS Conceptual Model
EL-PFDD Meeting
CureSHANK Consortium
Funding Opportunities
Research Resources
Landscape Analysis for Industry
Participate in Research
Support Our Work
Our Fundraisers
Take Action
Fundraise Online
Plan an Event
Media
Real Family Stories
Webinars
PMSAD
News
CureSHANK Pressroom
About Us
Board of Directors
Strategic & Scientific Advisors
Our Partners
Financials
Meet Our Team
Contact Us
Donate
Open Menu
Close Menu
Phelan-McDermid Syndrome
Folder:
For Academia & Industry
Back
Learn about our Initiatives
Our Research Grants
PMS Conceptual Model
EL-PFDD Meeting
CureSHANK Consortium
Funding Opportunities
Research Resources
Landscape Analysis for Industry
Participate in Research
Folder:
Support Our Work
Back
Our Fundraisers
Take Action
Fundraise Online
Plan an Event
Folder:
Media
Back
Real Family Stories
Webinars
PMSAD
News
CureSHANK Pressroom
Folder:
About Us
Back
Board of Directors
Strategic & Scientific Advisors
Our Partners
Financials
Meet Our Team
Contact Us
Donate
Community FAQ: jaguar GENE THERAPY
Feb 24
Written By
CureSHANK
Download the PDF here.
CureSHANK
Previous
Previous
Announcing the 2026 Phelan-McDermid Syndrome Drug Development Symposium
Next
Next
CureSHANK Community News: FEBRUARY 2026
